DE3021006C2 - Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung - Google Patents

Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung

Info

Publication number
DE3021006C2
DE3021006C2 DE3021006A DE3021006A DE3021006C2 DE 3021006 C2 DE3021006 C2 DE 3021006C2 DE 3021006 A DE3021006 A DE 3021006A DE 3021006 A DE3021006 A DE 3021006A DE 3021006 C2 DE3021006 C2 DE 3021006C2
Authority
DE
Germany
Prior art keywords
suspension
minutes
mixture
suspended
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3021006A
Other languages
German (de)
English (en)
Other versions
DE3021006A1 (de
Inventor
Fujiwara Akita Tetsuro
Takei Kuki Saitama Tsunetomo
Tanaka Toda Saitama Yuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13367224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3021006(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of DE3021006A1 publication Critical patent/DE3021006A1/de
Application granted granted Critical
Publication of DE3021006C2 publication Critical patent/DE3021006C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
DE3021006A 1979-06-02 1980-05-30 Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung Expired DE3021006C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6821179A JPS55160721A (en) 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent

Publications (2)

Publication Number Publication Date
DE3021006A1 DE3021006A1 (de) 1981-01-08
DE3021006C2 true DE3021006C2 (de) 1983-03-17

Family

ID=13367224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3021006A Expired DE3021006C2 (de) 1979-06-02 1980-05-30 Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung

Country Status (8)

Country Link
US (1) US4338301A (enExample)
JP (1) JPS55160721A (enExample)
AU (1) AU520543B2 (enExample)
CA (1) CA1161754A (enExample)
DE (1) DE3021006C2 (enExample)
FR (1) FR2457872A1 (enExample)
GB (1) GB2050832B (enExample)
MX (1) MX9203482A (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
DD225841C2 (de) * 1983-12-08 1986-04-16 Dresden Arzneimittel Verfahren zur herstellung eines mittels zur behandlung von erkrankungen, die mit veraenderungen des pulmonalen surfactant-systems einhergehen
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
FR2559669B1 (fr) * 1984-02-20 1986-05-09 Nabavi Seyfeddine Lipoproteine haute densite cholesterol synthetique
IL71051A (en) * 1984-02-23 1988-02-29 Yeda Res & Dev Compositions containing active lipids for the treatment of cystic fibrosis
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
AU3073789A (en) * 1988-03-31 1989-10-05 Abbott Laboratories Drug delivery using pulmonary surfactant to facilitate absorption
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
EP0904295B1 (en) * 1996-05-15 2005-08-10 ALTANA Pharma AG Process for separating and analyzing hydrophobic proteins using thin layer chromatography
US6855342B2 (en) * 2000-06-30 2005-02-15 Medicis Pharmaceutical Corporation Compositions and methods for high sorption of skin materials and delivery of sulfur
US6514489B1 (en) 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594476A (en) * 1969-05-12 1971-07-20 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
AU5867880A (en) 1981-12-10
FR2457872A1 (fr) 1980-12-26
FR2457872B1 (enExample) 1984-09-21
MX9203482A (es) 1992-08-01
JPS55160721A (en) 1980-12-13
GB2050832A (en) 1981-01-14
DE3021006A1 (de) 1981-01-08
CA1161754A (en) 1984-02-07
GB2050832B (en) 1983-08-03
US4338301A (en) 1982-07-06
AU520543B2 (en) 1982-02-04
JPS619925B2 (enExample) 1986-03-27

Similar Documents

Publication Publication Date Title
DE3021006C2 (de) Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung
DE3886970T2 (de) Natürliches oberflächenwirksames Lungenpräparat, Verfahren zu seiner Herstellung und pharmazeutische Zusammensetzungen.
DE3008082A1 (de) Carcinostatisches und die immunreaktion stimulierendes mittel, enthaltend lysophospholipid und phospholipid, und verfahren zur herstellung desselben
DE2248475C3 (de) Verfahren zur Gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren Hämoglobinlösungen
Hochschild Effect of dimethylaminoethyl p-chlorophenoxyacetate on the life span of male Swiss Webster albino mice
CH642852A5 (de) Material, das zur markierung mit einem radionuklid geeignet ist, verfahren zu dessen herstellung und dessen verwendung.
CH657049A5 (de) Kuenstliches oberflaechenaktives mittel fuer die lunge und heilmittel fuer syndrome von atemnot, die dieses als aktive komponente enthalten.
DE2602997C2 (de) Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung
EP0145005B1 (de) Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE2900887A1 (de) Verfahren zur gewinnung einer natuerlichen polarfraktion mit antipsoriatischer wirksamkeit
DE10141018A1 (de) Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
EP0406732B1 (de) Niedrig-viskose, hochkonzentrierte Surfactant-Suspension
DE1076888B (de) Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke
DE1620629C3 (de) Verwendung eines Salzes von 2-Merkaptoäthansulf onsäure zur Herstellung von Mukolytica
DE69500487T2 (de) Kosmetische oder dermatologische Zusammensetzung, die eingekapselte Maismehlextrakte enthält
EP1242825A2 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten
DE19522693A1 (de) Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
DE68903670T2 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
EP0348507A1 (de) Arzneimittelzubereitung für die individuelle prophylaxe venerischer krankheiten und zur heilung von urogenitaler trichomoniase
DE1293705B (de) Verfahren zur Gewinnung eines elastolytisch wirksamen Bauchspeicheldruesen-Praeparates
DE3309076A1 (de) Liposome und verfahren zu ihrer herstellung
CH640244A5 (en) Biologically active substance
DE69902866T2 (de) Extrakte aus kuhausscheidungen mit antikrebs- und antiinflammatorischer wirksamkeit sowie verfahren zu deren herstellung
DE2729903A1 (de) Antithrombosemittel
AT200257B (enExample)

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: PHOSPHOLIPIDFRAKTION AUS RINDERLUNGE MIT COLFOSCERILPALMITAT MIT PALMITINSAEURE MIT TRIPALMITAT; REGISTRATION NO/DATE: 18348.00.00, 19891025

Spc suppl protection certif: 193 75 100

Filing date: 19930701

V457 Spc granted

Free format text: PRODUCT NAME: PHOSPHOLIPIDFRAKTION AUS RINDERLUNGE MIT COLFOSCERILPALMITAT MIT PALMITINSAEURE MIT TRIPALMITAT; REGISTRATION NO/DATE: 18348.00.00, 19891025

Spc suppl protection certif: 193 75 100

Filing date: 19930701

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI-TOKYO PHARMACEUTICALS, INC., TOKIO, JP

V464 Spc expired

Free format text: PRODUCT NAME: PHOSPHOLIPIDFRAKTION AUS RINDERLUNGE MIT COLFOSCERILPALMITAT MIT PALMITINSAEURE MIT TRIPALMITAT; REGISTRATION NO/DATE: 18348.00.00, 19891025

Spc suppl protection certif: 193 75 100

Filing date: 19930701